Better health for people, Brighter future for the world. FY2021 Q1 EARNINGS ANNOUNCEMENT July 30, 2021 IMPORTANT NOTICE For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this presentation. This presentation (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does no ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2020 Earnings Conference Call May 11, 2021 8:00 AM ET Company Participants Christopher O'Reilly - Global Head, IR Christophe Weber - President & CEO Andy Plump - President, R&D Costa Saroukos - CFO Ramona Sequeira - President, U.S. Business Unit & Global Portfolio Commercialization Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants Shinichiro Muraoka - Morgan Stanley MUFG Ken Cacciatore - Cowen Hidemaru Yamaguchi - C ...

BETTER HEALTH FOR PEOPLE, BRIGHTER FUTURE FOR THE WORLD FY2020 Q4 Earnings Announcement May 11, 2021 Better Health, Brighter Future IMPORTANT NOTICE For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this presentation. This presentation (including any oral briefing and any question-and-answer in connection with it) is ...

WAVE 1 PIPELINE MARKET OPPORTUNITY CALL (PART 2) April 6th, 2021 Takeda Pharmaceutical Company Limited IMPORTANT NOTICE For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this release. This presentation (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not con ...

TAKEDA ONCOLOGY 2020 World Conference on Lung Cancer IR Event January 29, 2021 IMPORTANT NOTICE 2 For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this release. This presentation (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or ...

Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q3 2021 Earnings Conference Call February 4, 2021 6:00 AM ET Company Participants Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber - President & CEO Andrew Plump - President, Research & Development and Director Constantine Saroukos - CFO & Director Masato Iwasaki - President, Japan Pharma Business Unit & Director Julie Kim - President, Plasma-Derived Therapies Business Unit Ramona Sequeira - President, US Business Unit & Global Portfolio Commer ...

BETTER HEALTH FOR PEOPLE, BRIGHTER FUTURE FOR THE WORLD 39th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE JANUARY 11, 2021 Better Health, Brighter Future IMPORTANT NOTICE For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this presentation. This presentation (including any oral briefing and any question-and-answer in conn ...

Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q2 2021 Earnings Conference Call October 29, 2020 5:30 AM ET Company Participants Christopher O'Reilly - IR Christophe Weber - President, CEO & Representative Director Andrew Plump - President, Research & Development and Director Constantine Saroukos - CFO & Director Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants Fumiyoshi Sakai - Crédit Suisse Hidemaru Yamaguchi - Citigroup Kazuaki Hashiguchi - Daiwa Securities Shinichiro M ...

COMMITTED TO BRINGING BETTER HEALTH AND A BRIGHTER FUTURE TO PEOPLE WORLDWIDE FY2020 Q2 Earnings Announcement October 29, 2020 Better Health, Brighter Future IMPORTANT NOTICE 1 For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this presentation. This presentation (including any oral briefing and any question-and-answ ...